The novel SARS-CoV-2 has disproportionately affected older adults. Notably, the impact of the COVID-19 pandemic has had larger repercussions in countries with older population structures; data from large outbreaks in China, Italy, and most recently, the United States has shown a remarkable impact of SARS-CoV-2 infections on older patients, with increased disease severity, adverse outcomes and increased mortality ([@CIT0001]). This susceptibility has been suggested to be attributable to deleterious features of aging, particularly in those with cardio-metabolic and respiratory comorbidities. Tissue-specific expression of the *ACE2* gene, which encodes the SARS-CoV-2 receptor, has been linked to specific immune signatures in males and older adults and its expression have been shown to be age-dependent ([@CIT0004],[@CIT0005]); moreover, immunosenescence and increased inflammatory responses related to the aging process might lead to increased infection risk and dysregulated immune response to SARS-CoV-2 in older adults ([@CIT0006]). Given these mechanisms which may increase susceptibility in older individuals, the role of comorbidities and social inequities, which condition an increased burden on functionality and dependence, has often been overlooked over chronological aging as significant predictors of COVID-19 severity and lethality. In Mexico, COVID-19 has shown similar patterns on its impact on older adults, despite an apparent demographic dividend by having, on average, a younger population ([@CIT0007]). Mexico's younger population structure compared to European countries is nonetheless affected by increased rates of cardio-metabolic diseases, particularly Type 2 diabetes, obesity and the metabolic syndrome, with most individuals reaching older age with a significant number of comorbidities ([@CIT0008],[@CIT0009]). Recent shifts on aging structures within Mexico have resulted in an increased number of older adults who continue working into old age, most of whom live in poverty, do not have adequate healthcare access, and are dependent on the working-age population ([@CIT0007]). Poverty and low socioeconomic status are the result of structural inequality. According to the WHO report on social determinants of health, the circumstances of daily life are determined by structural drivers such as the nature and degree of stratification in society; biases, norms, and values within society; global and national economic and social policy; as well as processes of governance at the global, national, and local level. The combination of unequal structural factors, an aging population with increased prevalence of chronic diseases, and the co-existence of infectious diseases position Mexican older adults as a particularly susceptible population during the COVID-19 pandemic ([@CIT0010]). Given that most studies have linked an increased risk of COVID-19 with chronological age, many resource allocation decisions have been made purely on this basis, which represents an issue for geriatric care in the patient population facing the highest disease burden ([@CIT0011]). To address these gaps, we investigated health and structural determinants which could contribute to increased COVID-19 severity and lethality beyond chronological age in older Mexican adults to better characterize the impact of COVID-19 in older populations.

Methods {#s1}
=======

Data Sources {#s2}
------------

We analyzed data collected by the General Directorate of Epidemiology of the Mexican Ministry of Health, which is an open-source data set comprising daily updated suspected COVID-19 cases that have been tested using real-time RT-PCR to confirm SARS-CoV-2 according to the Berlin Protocol ([@CIT0012]), and were certified by the National Institute for Diagnosis and Epidemiological Referral ([@CIT0013]). Data to estimate population rates at different ages and population density was extracted from 2020 population projections obtained by the Mexican National Population Council (CONAPO). The 2015 social lag index (SLI), which is a composite of several factors which are measured to estimate social disadvantage and structural inequality at the municipal level based on population census data, was obtained from the Mexican National Evaluation Council (CONEVAL); SLI is a principal component score which comprises percentages of literacy, access to basic education, healthcare services, living conditions including drainage, dirt floor, access to water, electricity and electrical appliances for each Mexican municipality ([@CIT0014]). Data on available hospital beds at the end of 2019 were extracted from the Mexican Ministry of Health and were standardized to projected 2020 population figures from CONAPO ([@CIT0015]). For this work we considered all SARS-CoV-2 PCR-positive cases up to June 3, 2020 in individuals aged 60 and older.

Definitions of COVID-19 Cases, Predictors, and Outcomes {#s3}
-------------------------------------------------------

Suspected COVID-19 cases were defined as an individual of any age whom in the last 7 d has presented two or more of the following: cough, fever, or headache, accompanied by either dyspnea, arthralgias, myalgias, sore throat, rhinorrhea, conjunctivitis, or chest pain. Among suspected cases, the Ministry of Health establishes two protocols for case confirmation: (i) SARS-CoV-2 testing is done widespread for suspected COVID-19 cases with severe acute respiratory infection and signs of breathing difficulty or deaths with suspected COVID-19, (ii) for all other cases, a sentinel surveillance model is being utilized, whereby 475 health facilities which comprise a nationally representative sample evaluate \~10% of mild outpatient cases to provide estimates of confirmed mild cases ([@CIT0016]). Demographic and health data are collected and uploaded to the epidemiologic surveillance database by personnel from each corresponding healthcare facility. Available variables include age, sex, nationality, state, and municipality where the case was detected, immigration status as well as identification of individuals who speak indigenous languages from Mexico. Health information includes the status of diabetes, obesity, chronic obstructive pulmonary disease (COPD), immunosuppression, pregnancy, arterial hypertension, cardiovascular disease, chronic kidney disease (CKD), and asthma. Date of symptom onset, hospital admission, and death are available for all cases as are outpatient or hospitalized status, information regarding the diagnosis of pneumonia, ICU admission, and whether the patient required invasive mechanical ventilation.

Statistical Analysis {#s4}
--------------------

### Population-based statistics {#s5}

We estimated age-specific incidence and mortality rates by standardizing cases per 1-y increment to the corresponding projected population sizes and normalized it to reflect a rate per 100 000 inhabitants. Incidence and mortality rates were plotted against age and smoothed splines were fitted to model trends according to age profiles. Categorical variables were compared using the chi-squared statistic and stratified according to age.

### COVID-19 outcome models {#s6}

Given the large structural inequalities in healthcare access across Mexico, we fitted mixed-effects models which considered municipality of case occurrence as a random effect to control for potential inequalities in healthcare access, aging structures, and unequal regional evolution of the epidemic. These models would also allow to include multilevel data, to increase the precision of outcome estimates considering structural factors for each municipality. Models were fitted using mixed-effects logistic regression using the municipality of case occurrence as a random effect; *p* values and confidence intervals were estimated using the Laplace approximation within the *lme4* and *lmerTest* R packages.

### Risk of COVID-19 lethality in older adults {#s7}

To model COVID-19 mortality risk in older adults we fitted Cox proportional hazard regression models stratified by sex, including frailty penalties to accommodate multilevel data and random effects for the municipality of case occurrence, approximating iterations using the Newton--Raphson algorithm. Random effect estimates were exponentiated to calculate baseline mortality hazards across municipalities to represent geographical heterogeneity. Models were selected based on the Bayesian Information Criterion (BIC) and performance was assessed using Harrel's c-statistic. To visualize increases in lethality risk for continuous variables and quantify uncertainty for estimations, we performed postestimation simulations using bootstrapping with the *simPH* package. Proportional hazard assumptions were verified using Schoenfeld residuals.

### Impact of age, structural determinants, and comorbidities on mortality risk {#s8}

To investigate the role of age in predicting mortality compared to structural factors and comorbidities, we fitted sequential Cox proportional hazard models compared to only COVID-19 pneumonia as a predictor and introduced either age, structural factors (ie, SLI, private care), or increasing number of comorbidities as blocks. We compared models using changes in the BIC; the better models were those which either minimized or had large changes in BIC. We also separately analyzed outcomes and mortality for older adults without comorbidities to examine the role of structural factors compared to age in relation to disease severity and COVID-19 lethality. A *p* value of \< .05 was considered as the statistical significance threshold. All analyses were performed using R version 4.0.0.

Results {#s9}
=======

COVID-19 in Mexican Adults Aged 60 and Older {#s10}
--------------------------------------------

As of June 3, 2020, we observed 20 804 confirmed SARS-CoV-2 cases in adults aged 60 and older, representing 20.5% of all confirmed COVID-19 cases (*n* = 101 238, [Table 1](#T1){ref-type="table"}). Overall, the rate of positivity in older adults has been 43.8% which represents a ratio of 1.39:1 in positivity among all evaluated cases. Despite the higher positivity rate, mortality rates are disproportionally higher in this population segment. Among all 11 728 confirmed lethal cases, 6136 have been recorded in older adults, indicating significantly higher lethality (6.95% vs. 29.49%). When standardizing incidence rates to population estimates per each 1-y increase, the highest incidence rates occur between 55 and 65 y with a decrease in those aged older than 65 y; regardless, mortality remains steadily higher for adults aged 60 and older ([Figure 1A](#F1){ref-type="fig"} and [B](#F1){ref-type="fig"}). Similarly, higher disease severity as assessed by hospitalization and ICU admission rates, as well as requirements for invasive ventilation, were more frequent in older adults. Furthermore, most comorbidities were clustered in older individuals and the rates of individuals having 2 or more comorbidities were markedly higher for older adults (24.0% vs. 11.6%, *p* \< .001, [Figure 1C](#F1){ref-type="fig"} and [D](#F1){ref-type="fig"}).

###### 

Descriptive Statistics Positive SARS-CoV-2 Cases in Mexico on June 3, 2020

  Comorbidities           Age\<60 *n* = 80 434   Age≥60 *n* = 20 804   *p* value
  ----------------------- ---------------------- --------------------- -----------
  Diabetes (%)            9956 (12.4)            7533 (36.2)           \<.001
  COPD (%)                692 (0.9)              1298 (6.2)            \<.001
  Asthma (%)              2510 (3.1)             420 (2)               \<.001
  Immunosuppression (%)   1036 (1.3)             519 (2.5)             \<.001
  Hypertension (%)        11 362 (14.1)          9593 (46.1)           \<.001
  Other (%)               2273 (2.8)             920 (4.4)             \<.001
  CVD (%)                 1211 (1.5)             1383 (6.6)            \<.001
  Obesity                 16 463 (20.5)          4136 (19.9)           .0622
  CKD (%)                 1316 (1.6)             1023 (4.9)            \<.001
  Smoking (%)             6518 (8.1)             1815 (8.7)            .0039
  Men(%)                  44 742 (55.6)          12 257 (58.9)         \<.001
  Pneumonia(%)            16 735 (20.8)          10 190 (49)           \<.001
  Hospitalization(%)      21 503 (26.7)          13 374 (64.3)         \<.001
  ICU admission (%)       1903 (2.4)             1556 (7.5)            \<.001
  Mortality (%)           5592 (vii)             6136 (29.5)           \<.001

*Note:* COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; CVD = cardiovascular disease; ICU = intense care unit.

![COVID-19 cases (**A**) and mortality rates (**B**) standardized according to age-specific population projections for 2020 for each 1-y increment. The figure also displays the distribution of lethal and nonlethal cases stratified by age group, comparing younger and older adults according to date of symptom onset to demonstrate the disproportionate number of lethal cases in older adults (**C**) and distribution of COVID-19 outcomes comparing rates between those ≤60 and \>60 y, with (1+C) and without comorbidity (0C), to demonstrate the impact of comorbidity in modifying outcomes independent of age (**D**).](glaa163f0001){#F1}

COVID-19 Outcomes and Disease Severity in Older Adults {#s11}
------------------------------------------------------

We identified that increasing age, male sex, smoking, diabetes, and obesity were associated with increased pneumonia risk; similarly, for hospitalization we identified an increased risk for older adults with obesity, CKD, COPD, diabetes, increasing age, and male sex. Notably, both pneumonia and hospitalization risk were higher among older adults living in municipalities with high SLI, indicating an effect of structural inequalities besides the aforementioned comorbidities in further increasing COVID-19 severity ([Figure 2](#F2){ref-type="fig"}). When assessing ICU admission risk factors, we identified increased likelihood with obesity, male sex and higher SLI; similarly, the risk for invasive ventilation was higher for older adults with obesity and municipalities with high SLI. Notably, in older adults without comorbidities (*n* = 5746), age alone was not a significant predictor of requirement for invasive ventilation or ICU admission. We only observed a significant role for age in predicting pneumonia and risk of hospital admission; moreover, the SLI alone was associated with increased risk of pneumonia (OR 1.45, 95% CI 1.21--1.74), hospitalization (OR 1.52, 95% CI 1.24--1.87), and requirements for invasive ventilation (OR 1.38, 95% CI 1.07--1.78) in older adults without comorbidity.

![Risk factors for COVID-19-related pneumonia, hospitalization, and ICU admission in older Mexican adults, modeled using logistic with mixed effects, including municipality of case occurrence as a random effect to control for regional inequalities.](glaa163f0002){#F2}

Health and Structural Determinants of COVID-19 Mortality in Older Adults {#s12}
------------------------------------------------------------------------

Besides comorbidities, we identified that the SLI was a predictor of COVID-19 lethality adjusted for age and sex (HR 1.133, 95% CI 1.054--1.217); the number of hospital beds per 1000 individuals was not a protective factor for mortality (HR 0.996, 95% CI 0.990--1.002) but receiving treatment within a private healthcare facility was (HR 0.444, 95% CI 0.368--0.535). In multivariable analyses, we identified a higher mortality risk associated with age, comorbid diabetes, obesity, immunosuppression, and CKD. Being treated in a public care facility and living in municipalities with increased values of the SLI were also predictors of COVID-19 lethality ([Figure 3A](#F3){ref-type="fig"}).

![Risk factors for COVID-19 lethality in older Mexican adults, using Cox proportional Hazard regression models with frailty penalty to accommodate multilevel data (**A**). (**B**) shows the changes in the Bayesian Information Criteria to estimate the role of age, structural factors, and comorbidities in improving COVID-19 lethality risk predictions M0 is the reference model, which includes sex and COVID-19 pneumonia, M1 = M0 + Social lag index, M2 = M0 + Age, M3 = M0 + Age + Social lag index, M4 = M0 + Comorbidities, M5 = M0 + Comorbidities + Social lag index, M6 = M0 + Comorbidities + Age, M7 = M0 + Age + Social lag index + Comorbidities comparing subjects with and without comorbidities. We also include postestimation simulations to quantify the effect of covariates in increasing COVID-19 lethality risk for age compared to the median in older adults (72 y, **C**), an increasing number of comorbidities (**D**) and increases in the SLI (**E**).](glaa163f0003){#F3}

Role of Structural Determinants, Comorbidities, and Age on COVID-19 Severity and Lethality {#s13}
------------------------------------------------------------------------------------------

To assess improvements in model performance, we examined the effect of age, structural factors, and comorbidities in improving prediction of COVID-19 lethality. Overall, comorbidities offered the larger changes in predictive improvement for mortality, followed by its combination with structural factors; models that included age had smaller changes in BIC. Similarly, the combination of comorbidities and structural factors showed lower BIC values compared to the combination of either with age ([Figure 3B](#F3){ref-type="fig"}). The better model, which included age, structural factors, and comorbidities only showed marginal improvements in predictive ability compared to the model which excluded age (c-statistics 0.661 vs. 0.642, respectively). To isolate the effect of age, we analyzed older adults without comorbidities; in these individuals, the SLI was a risk factor (HR 1.21, 95% CI 1.06--1.38) and treatment in private care facilities a protective factor (HR 0.39, 95% CI 0.26--0.58) for mortality (c-statistic = 0.676). Addition of age offered additional decreases in BIC, and increased the overall predictive capacity of the model (c-statistic = 0.687). Overall, in individuals without comorbidities, additional consideration of structural factors improved prediction of mortality compared to age alone. Similarly, obesity remained as a significant predictor of mortality even in individuals without other comorbidities (HR 1.17, 95% CI 1.01--1.34) and was also a predictor of increased risk of pneumonia (OR 1.76, 95% CI 1.51--2.06), hospitalization risk (OR 1.45, 95% CI 1.23--1.71), ICU admission (OR 1.53, 95% CI 1.14--2.05) and requirement of invasive ventilation (OR 1.50, 95% CI 1.13--2.05), over chronological age. These latter findings suggest that the obesity paradox observed in other acute respiratory infections is not present in older individuals ([@CIT0017]).

Postestimation Simulation of Mortality Risk Prediction for Continuous Variables {#s14}
-------------------------------------------------------------------------------

When running postestimation simulations in the model with all three categories, we identified that compared to median age among older adults (72 y), those younger than the median had lower mortality risk compared to those above. However, despite age being a predictor of mortality, we did not observe significantly higher risk in individuals aged older than 80 compared to individuals aged 70--80 y. Similarly, an increasing number of comorbidities and living in municipalities with increasing SLI were also related to monotonic increases in mortality risk ([Figure 3C--E](#F3){ref-type="fig"}). We hypothesized that COVID-19 outcomes would be geographically heterogeneous; therefore, we fitted mixed-effect models considering the municipality of case occurrence as a random effect. When considering baseline mortality hazard for older adults with COVID-19 across Mexican municipalities, we identified significant disparities; notably, higher risk areas were related to municipalities with higher SLI which were mostly nearby metropolitan areas ([Figure 4A](#F4){ref-type="fig"}). Furthermore, when plotting baseline hazard ratios using the number of hospital beds available per 1000 inhabitants, we observed that higher risk occurred in municipalities with five or fewer beds per 1000 inhabitants. Since the distribution of cases has not been homogeneous and most high-risk areas were near metropolitan areas, we performed a subanalysis restricted to those locations (*n* = 15 965, 4592 deaths). Interestingly, the SLI remained as a significant predictor of mortality in metropolitan areas (HR 1.37, 95% CI 1.13--1.65), as was being treated in a private care facility (HR 0.39, 95% CI 0.30--0.49), adjusted for age and sex; however this was not observed for nonmetropolitan areas where the SLI was not predictive of mortality (HR 1.01, 95% CI 0.91--1.13), suggesting a rural-urban dissociation on the factors which impact lethality.

![Geographical distribution of baseline COVID-19 lethality hazards across Mexican municipalities as modeled by mixed-effects Cox proportional risk regression models with frailty penalties (**A**). We also show hazard of individual municipalities and the number of beds per 1000 inhabitants in each municipality considering also a state-wide mortality hazard (blue line, **B**).](glaa163f0004){#F4}

Discussion {#s15}
==========

Here, we demonstrate the role of health and structural socioeconomic determinants---as proxied by the SLI and private versus public healthcare delivery---in increasing COVID-19 lethality and disease severity independent of age in older Mexican adults. Notably, we observed that while age is a significant independent predictor of COVID-19 lethality, comorbidities, and structural health determinants likely play a larger role in increasing disease severity and conditioning risk of COVID-19 lethality in older patients. In older adults without comorbidities, age was not a predictor of disease severity with structural factors playing a larger role; in addition, mortality prediction in individuals without comorbidities improved only marginally when considering chronological age added to structural factors. We therefore confirmed a worrisome association of increased COVID-19 lethality with increasing values of the SLI, which considers deficiencies or unequal access to education, healthcare, living conditions, and basic services; furthermore, being treated in private facilities also decreases the risk of COVID-19 lethality, suggesting a significant gap between care received in public compared to private facilities for older adults or better accessibility for private care. These results suggest that the consequences of large socioeconomic inequalities within Mexico represent added burdens to multimorbidity in older adults, and both of which are better predictors of mortality compared to chronological age alone. These conditions must be addressed as the pandemic transitions to more rural areas where limited access to health services and older population structures with adverse multimorbidity profiles increase mortality risk.

Data from countries affected by the COVID-19 pandemic have reported higher mortality rates in older adults, particularly in those with an increasing number of comorbidities ([@CIT0018]). These observations have led to distinct problems concerning healthcare decisions in the face of COVID-19. Given the overwhelming effect of COVID-19 on healthcare burden for countries with older population structures, many systems have opted for health resources to be allocated based mainly on chronological age ([@CIT0019],[@CIT0020]). While evidence of an age-dependent increase in the expression of the *ACE2* gene has been reported and an increasing number of comorbidities are readily observed in older adults with COVID-19, data which demonstrates biological effects of chronological aging over multimorbidity and health disparities on outcomes has not been reported ([@CIT0005],[@CIT0021]). Instead, additional effort should be carried out to reduce disparities in healthcare access, reduce socioeconomic inequalities, and improve care in older adults with multimorbidity to reduce its effect on COVID-19 outcomes, given their concomitant effects along with chronological age in increasing COVID-19 severity and lethality ([@CIT0022],[@CIT0023]). A previous analysis by our group which considered COVID-19 cases in Mexico highlighted how the cardio-metabolic burden in younger patients approximated mortality risk to those observed in older COVID-19 patients without comorbidity ([@CIT0024]). Our results in this present study show that chronological age only offers modest improvements in mortality risk prediction and does not predict disease severity in older adults without comorbidities. This evidence advocates for bioethical decisions on resource allocation in overwhelmed healthcare systems to not be based on chronological age as an exclusive criterion, but rather to integrally consider comorbidity profiles, functional status and other markers of biological aging along with establishing a framework which works towards ameliorating the impact of socioeconomic inequalities on COVID-19 outcomes for older adults as the pandemic progresses.

The response of Mexican authorities to promote social distancing among older adults has thus far been consistent. A nation-wide stipend was established the Mexican government to support older adults throughout Mexico and, recently, advanced payments were released to reduce the financial burden of COVID-19 ([@CIT0025]). Despite these policies, our data shows that older adults who live in highly marginalized municipalities remain at higher risk of COVID-19 severity and mortality, which might likely indicate unaddressed gaps that must be considered to reduce the impact of COVID-19 on older adults, particularly from highly marginalized communities and ethnic groups within Mexico ([@CIT0026]). Inequalities which might arise once social distancing is lifted must also be addressed to facilitate reincorporation of older adults into daily life after the pandemic and geriatric care must be secured to reduce the impact of social distancing on the general health and function of older adults, particularly those living in isolation and with multimorbidity ([@CIT0027]).

Obstacles for healthcare access in older adults have been consistently associated with worsened outcomes and increased all-cause mortality, particularly for those facing social inequalities ([@CIT0028]). Previous research has shown that negative self-perceived aging influences healthcare-seeking behavior, particularly in settings of limited healthcare access ([@CIT0029],[@CIT0030]). Our results suggest that reduced healthcare access, as measured by increases in the SLI, is associated with increased COVID-19 severity and lethality in older adults, likely reflecting the effect of structural inequalities across Mexican municipalities. A recent geroscience approach to the COVID-19 pandemic in the United States, Italy, and China demonstrated an exponential increase in COVID-19 lethality with age and similarly observed male-biased mortality as in the Mexican data, potentially implicating aging mechanisms into COVID-19 lethality in older adults ([@CIT0031]). However, as shown by our results, in older adults without comorbidities the effect of age was not a predictor of disease severity; furthermore, structural factors and comorbidities were better predictors of mortality compared to chronological age alone. These findings on the adverse impacts of structural factors in individual clearly relate the individual with its environment are in line with the multidimensional concept encapsulated by intrinsic capacity, which also includes a composite of physical and mental capacities which define and individual's functional ability. These deficits might be responsible for the increased COVID-19 risk observed in older adults. Intrinsic capacity should be evaluated as a risk factor for COVID-19 and other infectious diseases in older adults in future studies to better understand it as a predictor of mortality over chronological aging ([@CIT0032],[@CIT0033]). Similarly, biological markers and clinical measures could be used to estimate biological aging and its potential impact on COVID-19 outcomes, and which are likely to better predict fatality risk in older adults; these metrics should be evaluated to better reflect risk attributable to aging in COVID-19 ([@CIT0034],[@CIT0035]).

Ageism and self-perceived aging might impact healthcare-seeking decisions in older adults, particularly under a widespread perception of increased healthcare burden during the COVID-19 pandemic ([@CIT0011],[@CIT0036]). An additional factor to consider in this setting is the fact that awareness of COVID-19 symptoms is directed towards typical disease presentations and might not account for atypical symptoms and presentations which are more likely to occur in older patients ([@CIT0037],[@CIT0038]). Overall, given the significant impact of COVID-19 on older adults, our findings call for more integral approaches to spread awareness of COVID-19 in older adults in Mexico and other countries, addressing information gaps which might reduce healthcare-seeking behavior and reducing ageism as a criterion for bioethical decision-making. Moreover, evidence regarding atypical COVID-19 presentations and identifying factors that decrease mortality in older adults to increase awareness and promote healthcare-seeking behavior in high-risk remain as a relevant unaddressed gap which must be undertaken by future studies

Our approach is robust given that it considers national data on all confirmed COVID-19 cases in older adults with significant representation of most regions within Mexico. Inclusion of multilevel data allowed us to identify structural factors related to COVID-19 lethality and outcomes and to contrast the role of these factors and comorbidities as predictors of COVID-19 severity and mortality, highlighting areas of opportunity to address these and future affections which will likely also impact older adults. A potential limitation of our study is the lack of symptom-specific data which could be helpful to characterize atypical presentations of COVID-19 in older adults and identify early predictors of disease severity and potential recovery as has been seen in some series, and which remains to be addressed in future studies to better characterize the course of COVID-19 in older adults ([@CIT0039]). A relevant limitation of our work could be related to underreporting of mild cases in marginalized areas due to a lack of widespread testing, which might inflate mortality estimates for those regions, but which also would indicate a significant challenge for handling the COVID-19 epidemic in marginalized communities moving forward. Similarly, care should be taken when interpreting data on COVID-19 outcomes in private and public facilities, as it is impossible to discern to what extent improved outcomes result from differences in the severity of admitted and reported cases not captured in the gross data, with increased admission and reporting of mild cases in private hospitals, differences in socioeconomic status and other un-identified predictors of COVID-19 outcomes in patient populations, or differences in quality of care. Finally, consideration of additional measures not included in our study for assessment of disability, functionality and dependence are required to adequately analyze subjects with and without comorbidities and quantify the impact of such conditions on COVID-19, remaining as an area of opportunity for future research. Our findings could inform public policy related to ethical decision making for older adults by prompting consideration of factors beyond chronological age and promote further studies in older populations, which remains imperative to address aging in populations undergoing an epidemiological transition with increased morbidity burden, such as Mexico.

In conclusion, we characterized predictors of COVID-19 outcomes in older Mexican adults, including potential predictors related to structural inequalities which increase COVID-19 severity and lethality risk. We demonstrated that comorbidity profiles and structural factors are better predictors of COVID-19 severity and mortality compared to chronological age. Overall, baseline COVID-19 mortality hazards are unequally distributed for older adults in Mexico. Special attention should be given to underprivileged older populations to ameliorate the impact of these factors which increase lethality in older adults with multimorbidity. These findings could aid in shifting the current clinical and ethical decision-making focus away from chronological aging and onto a more integral and comprehensive geriatric care approaches.
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